🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
Non-Nutrient/Non-Botanical Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

3 mg
📊 Market median: 3.0mg (984 products) 📚 236 studies (Tier A: 2, B: 109)
This product: 3mg UL 10mg

Other Ingredients

Microcrystalline Cellulose Stearic Acid Magnesium Stearate Silica

Label Claims — Verification

All Other
All Other (100% of products) Structure/Function (86% of products) Nutrient (7% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Adults- take one tablet, preferably 20 minutes before bedtime, as a dietary supplement or as directed by a doctor.

⚠️ Warnings & Precautions

Warnings: For adult (18 years of age and over) use only.

Not for use by children, teenagers, pregnant and lactating women.

Not for use by children, teenagers, pregnant and lactating women. Consult a physician before use if you are a woman of childbearing age or if you are currently taking any medication.

Do not take this product if you have autoimmune conditions, depressive disorder, heart, liver, kidney or any other disease without consulting a physician. Do not take this product prior to driving a motor vehicle or operating machinery.

As with any supplement, if you are pregnant, nursing, or have a medical condition, or taking medication, consult your physician.

Keep out of reach of children.

Tamper evident: Do not use if sealed blister units are broken or damaged.

Additional Information

Unit Dose

50 Tablets (5 x 10)

Store at room temperature in a dry place.

Re-order No.: 700825 M-95 Rev. 10/16

Product Details

UPC / SKU 3 09045 18206 2
DSLD Entry Date 2019-04-25
Product Type Non-Nutrient/Non-Botanical
Form Tablet or Pill
DSLD ID 202164
Data Updated 2026-04-11

Research Evidence

291 Research Sources
55 Avg Quality Score
129 Meta Analysis
93 Systematic Review
51 Rct
11 Clinical Trial
2 Other
2 Regulatory Source
1 Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021
View all evidence for Melatonin →

Compare Similar Products

View all Melatonin products →